Policlinica CCBR S.R.L.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
Policlinica CCBR S.R.L. is evaluating innovative therapies for heart failure. The goal is to lower the risk of cardiovascular death and hospital visits.
- Heart failure
A group of investigators is leading multiple cardiovascular studies at the Bucharest site.
Digestive System Diseases
Clinical research at the clinic focuses on advancing care for ulcerative colitis. Long‑term treatment strategies are being examined to improve disease control.
- Ulcerative colitis
The digestive‑system portfolio includes several ongoing trials with dedicated research staff.
Immune System Diseases
The site is testing new agents for autoimmune conditions such as systemic lupus erythematosus. Studies also address related disorders to enhance overall immune health.
- Systemic lupus erythematosus
- Sjögren's disease
- Systemic sclerosis
- Psoriatic arthritis
- Rheumatoid arthritis
Over a dozen immune‑system trials are active, supported by a multidisciplinary team.
Musculoskeletal Diseases
Research efforts aim to relieve joint pain and improve function in patients with knee osteoarthritis. Combination approaches are explored to reduce disability.
- Knee osteoarthritis
- Rheumatoid arthritis
Musculoskeletal studies at Policlinica CCBR involve both pain management and disease‑modifying strategies.
Neoplasms
Oncology trials are assessing novel therapies for head and neck squamous cell carcinoma. The objective is to improve response rates in recurrent or metastatic disease.
- Recurrent or metastatic head and neck squamous cell carcinoma
The cancer research program collaborates with leading oncologists to expand treatment options.
Nervous System Diseases
Investigators are evaluating preventive treatments for migraine. The aim is to reduce attack frequency and severity for patients who have failed prior options.
- Migraine
Neurology studies are conducted with a focus on patient‑centered outcomes.
Nutritional and Metabolic Diseases
The clinic is exploring weight‑management interventions for individuals with obesity. Research seeks to combine lifestyle changes with emerging pharmacologic agents.
- Obesity
Metabolic studies are designed to address both weight loss and associated joint health.
Skin and Connective Tissue Diseases
Trials target skin‑related autoimmune conditions such as moderate to severe plaque psoriasis. Efforts also include evaluating disease‑modifying therapies for related connective‑tissue disorders.
- Moderate to severe plaque psoriasis
- Psoriatic arthritis
Dermatology and rheumatology teams work together to bring new options to patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 8 therapeutic areas and 15 of 33 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 9 by active trials.
lock +8 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Policlinica CCBR S.R.L.
lock Showing 1 of 26 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Deucravacitinib (BMS-986165) in Pediatric Subjects with Moderate to Severe Plaque Psoriasis | Bristol-Myers Squibb Services Unlimited Company | Phase III | Recruiting | May 2021 | — |
IMP list
lock Showing 1 of 33 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Deucravacitinib | 3 | Unknown | 2021-05-07 | 2023-05-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.